Helping to defuse the diabetes
The number of people in the world currently with type 1 diabetes is around 17 million and increasing rapidly. Already there are hundreds of thousands of deaths directly resulting from the disease. In order to halt, and reverse this rise we need to be able to detect and treat the disease at the earliest possible stage, before physical symptoms become apparent.
Type 1 time-bomb
Although there is still no cure for juvenile diabetes early detection can reduce the likelihood of long-term complications, both improving the quality of life and reducing the costs that result from repeated hospitalizations. PerkinElmer Life and Analytical Sciences methods provide the information needed to allow doctors to prepare for treatment to delay or prevent clinical onset of diabetes. As possibilities for therapy develop, the full value behind PerkinElmer's early detection philosophy will be realized. The number of cases of type 1 diabetes is increasing in almost all countries.
Global estimates of diabetes type
PerkinElmer Life and Analytical Sciences probes specific for HLA and non-HLA alleles are currently used exclusively for research to discover the genes involved in conferring a genetic risk of, or protection from developing type 1 diabetes.
To investigate which alleles are present, the gene segment of interest is amplified from the baby's blood cells dried on a blood collection card.
This technique for large scale screening can identify those children at risk and who then need careful follow up. This knowledge increases awareness and understanding in the parents, which will ultimately lead to better care for the child. 
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